Contract facts
NONEPROVIDE MEDICAL LABORATORY TESTING SERVICES FOR THE DETECTION OF ANTIGEN AND ANTIBODIES OF HUMAN IMMUNODEFICIENCY VIRUS(ES) (HIV), HEPATITIS B SURFACE ANTIBODY (HBSAB), HEPATITIS B SURFACE ANTIGEN (HBSAG), AND HEPATITIS C VIRUS (ANTI-HCV) is a federal NONE award for W40m Usa Hca held by Center for Disease Detection, LLC. Estimated value —. Related solicitation W81K0424R0018.
PROVIDE MEDICAL LABORATORY TESTING SERVICES FOR THE DETECTION OF ANTIGEN AND ANTIBODIES OF HUMAN IMMUNODEFICIENCY VIRUS(ES) (HIV), HEPATITIS B SURFACE ANTIBODY (HBSAB), HEPATITIS B SURFACE ANTIGEN (HBSAG), AND HEPATITIS C VIRUS (ANTI-HCV)
Incumbent footprint
Public recordCenter for Disease Detection, LLC — $31.1M obligated across 17 awards (firm-wide, all agencies).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W81K0425DA002?
W81K0425DA002 (HIV HBSAB services) is a W40m Usa Hca award with an estimated value of —, currently held by Center for Disease Detection, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded W81K0425DA002?
W40m Usa Hca awarded W81K0425DA002 to Center for Disease Detection, LLC.
Who is the incumbent on W81K0425DA002?
Center for Disease Detection, LLC is the incumbent with $31.1M across 17 related awards in SCOUT’s public footprint.
When does Center for Disease Detection, LLC’s W81K0425DA002 come up for recompete?
SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.